U.S. Markets closed

Catalent, Inc. to Present at Three Upcoming Investor Conferences

SOMERSET, N.J.--(BUSINESS WIRE)--

Catalent, Inc. (CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, and Thomas Castellano, Vice President Finance, Investor Relations and Treasurer will present at the following conferences in the coming weeks.

Stephens New York Investment Conference 
Location: New York, NY 
Date: Wednesday, November 7, 2018 
Presentation: 11:15 a.m. ET

Jefferies London Healthcare Conference 
Location: London, England 
Date: Thursday, November 15, 2018 
Presentation: 3:20 p.m. GMT

Piper Jaffray 30th Annual Healthcare Conference 
Location: New York, NY
Date: Wednesday, November 28, 2018 
Presentation: 8:30 a.m. ET

A live webcast of the presentations will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across 5 continents and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: https://www.businesswire.com/news/home/20181031005817/en/